Contrarily, antibody-mediated inhibition of VEGF in prostate cancer led to complete suppression of angiogenesis and prevents tumour growth beyond the initial prevascular growth phase (Borgstrom et al, 1998). The gene discussed is VEGFA; the disease is prostate carcinoma.